Anthony Caggiano
Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer | $503,010 | $927,894 |
| 2024 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer | $486,000 | $1,146,266 |
| 2023 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer | $446,250 | $972,124 |
| 2022 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer | $424,183 | $636,267 |
| 2021 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer | $92,788 | $1,684,491 |
| 2020 | Cognition Therapeutics Inc (CGTX) | M.D., Ph.D. Chief Medical Officer | $370,000 | $381,400 |
Earnings-call appearances
-
Cognition Therapeutics Inc Q4 FY2024 Earnings Call2025-03-20
Cognition Therapeutics Inc (CGTX)
-
Cognition Therapeutics Inc Q1 FY2024 Earnings Call2024-05-07
Cognition Therapeutics Inc (CGTX)